Related Experiment Video
Updated: Jul 16, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Selective digestive decontamination in multiple trauma patients: cost and efficacy
A Langlois-Karaga1, M Bues-Charbit, A Davignon
1Hôpital Nord, Chemin des Bourelly, Marseille, France.
Abstract:
A double-blind randomized placebo-controlled study was carried out to evaluate the efficacy and the cost of selective digestive decontamination (SDD) to prevent nosocomial pneumonia in multiple-trauma patients. Nosocomial infections, particularly pneumonia, were more frequent in the placebo group. The most common infectious agent was Staphylococcus: Staphylococcus aureus in the placebo group and Staphylococcus epidermidis in the SDD group. Methicillin-resistant Staphylococcus epidermidis was detected more often in the SDD group. No methicillin-resistant Staphylococcus aureus was observed in this study. Fewer patients in the SDD group required antibiotherapy. SDD resulted in a saving of about 41% in drug expenditure.
Insights
Selective digestive decontamination (SDD) reduced nosocomial pneumonia in trauma patients and cut drug costs by 41%. However, it increased methicillin-resistant Staphylococcus epidermidis.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Surgical Infections
Background:
- Nosocomial pneumonia is a significant complication in multiple-trauma patients.
- Preventive strategies are crucial to reduce infection rates and improve patient outcomes.
- Selective digestive decontamination (SDD) is a potential method for infection prevention.
Purpose of the Study:
- To evaluate the efficacy of SDD in preventing nosocomial pneumonia in multiple-trauma patients.
- To assess the cost-effectiveness of SDD regarding drug expenditure.
- To identify the impact of SDD on the spectrum of infectious agents, including resistant strains.
Main Methods:
- A double-blind, randomized, placebo-controlled study design.
- Inclusion of multiple-trauma patients requiring intensive care.
- Administration of SDD or placebo, with monitoring for nosocomial infections and antibiotic use.
Main Results:
- Nosocomial infections, particularly pneumonia, were significantly less frequent in the SDD group compared to the placebo group.
- While Staphylococcus aureus was more common in the placebo group, Staphylococcus epidermidis predominated in the SDD group.
- The SDD group showed an increase in methicillin-resistant Staphylococcus epidermidis, but no methicillin-resistant Staphylococcus aureus was detected.
- Patients in the SDD group required less antibiotherapy, leading to approximately 41% savings in drug expenditure.
Conclusions:
- SDD is effective in reducing nosocomial pneumonia and associated antibiotic use in multiple-trauma patients.
- SDD offers significant cost savings in drug expenditure.
- Surveillance for resistant organisms like MRSE is important during SDD implementation.
More Related Videos
Related Concept Videos
What is Monogastric Digestion?
Prevention of Further Absorption of Poison
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Pharmaceutical Poisoning: Treatment Strategies

